StonvexLoading…
StonvexStonvexStonvexCore line items from FOUR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.12B | $4.18B | $2.99B | $1.81B |
Operating Income | $50.00M | $351.00M | $223.10M | $108.50M |
Net Income | $15.00M | $119.00M | $78.80M | $50.70M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $8.76B | $8.71B | $8.99B | $6.99B |
Total Liabilities | $6.98B | $6.76B | $6.76B | $4.97B |
Cash & Equivalents | $473.00M | $964.00M | $1.51B | $3.03B |
Free Cash Flow OCF − CapEx | $128.00M | $624.00M | $401.50M | $236.10M |
Shares Outstanding | Not available | 1.33M | Not available | Not available |